STRATEGIC MARKETING INNOVATIONS

Lobbying for CIVICA RX · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Utah · House · Senate · $10,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Onshoring domestic pharmaceutical industrial base

Defense

Onshoring domestic pharmaceutical industrial base

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.